RPL39 and ovarian cancer: We analyzed the prognostic value of RPL39 in patients with ovarian cancer, and found that the overexpression of RPL39 protein in 1074 patients with EOC was associated with a shorter OS than that in the 361 of those with a lower AGK protein expression (HR = 1.31, Logrank P = 0.00034, Fig. 7I).